Macrophage-tumour cell interactions: Identification of MUC1 on breast cancer cells as a potential counter-receptor for the macrophage-restricted receptor, sialoadhesin

Immunology

Volumn 98, Issue 2, 1999, Pages 213-219

  Nath, D ^a,b   Hartnell, A ^a,b,c   Happerfield, L ^c   Miles, D W ^c   Burchell, J ^c   Taylor Papadimitriou, J ^c   Crocker, P R ^a,b,d  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^c IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^d UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR; GLUCOSAMINE; IMMUNOGLOBULIN G1; LIGAND; MUCIN; RECOMBINANT PROTEIN; SIALIC ACID; SIALOADHESIN; SIALOGLYCOPROTEIN;

ANIMAL CELL; ARTICLE; BREAST CANCER; CELL INTERACTION; CELL LYSATE; CELL STRAIN MCF 7; CONTROLLED STUDY; HUMAN; HUMAN CELL; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; TUMOR CELL LINE;

BLOTTING, WESTERN; BREAST NEOPLASMS; CA-15-3 ANTIGEN; CELL ADHESION MOLECULES; DISEASE PROGRESSION; FEMALE; FLOW CYTOMETRY; HUMANS; MACROPHAGES; MEMBRANE GLYCOPROTEINS; PROTEIN BINDING; RECEPTORS, IMMUNOLOGIC; TUMOR CELLS, CULTURED;

EID: 0032862879     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1999.00827.x     Document Type: Article

References (42)

1. 1. O'SULLIVAN C. & LEWIS C.E. (1994) Tumour-associated leucocytes: friends or foes in breast carcinoma. J Pathol 172, 229.
2. 2. O'SULLIVAN C., LEWIS C.E., HARRIS A.L. & MCGEE J.O. (1993) Secretion of epidermal growth factor by macrophages associated with breast carcinoma. Lancet 342, 148.
3. 3. LEWIS C.E., LEEK R., HARRIS A. & MCGEE J.O. (1995) Cytokine regulation of angiogenesis in breast cancer: the role of tumor-associated macrophages. J Leukocyte Biol 57, 747.
4. 4. LEEK R.D., LEWIS C.E., WHITEHOUSE R., GREENALL M., CLARKE J. & HARRIS A.L. (1996) Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res 56, 4625.
5. 5. MANTOVANI A., BOTTAZZI B., COLOTTA F., SOZZANI S. & RUCO L. (1992) The origin and function of tumor-associated macrophages. Immunol Today 13, 265.
6. 6. OWEN M.R. & SHERRATT J.A. (1997) Pattern formation and spatiotemporal irregularity in a model for macrophage tumour interactions. J Theor Biol 189, 63.
7. 7. DECKER T., LOHMANN-MATTHES M.L. & GIFFORD G.E. (1987) Cell-associated tumor necrosis factor (TNF) as a killing mechanism of activated cytotoxic macrophages. J Immumol 138, 957.
8. 8. CROCKER P.R., MUCKLOW S., BOUCKSON V. et al. (1994) Sialoadhesin, a macrophage sialic acid binding receptor for haemopoietic cells with 17 immunoglobulin-like domains. EMBO J 13, 4490.
9. 9. NATH D., VAN DER MERWE P.A., KELM S., BRADFIELD P. & CROCKER P.R. (1995) The amino-terminal immunoglobulin-like domain of sialoadhesin contains the sialic acid binding site. J Biol Chem 270, 26184.
10. 10. KELM S., PELZ A., SCHAUER R. et al. (1994) Sialoadhesin, MAG and CD22 define a new family of sialic acid-dependent adhesion molecules of the immunoglobulin superfamily. Curr Biol 4, 965.
11. 11. CROCKER P.R., KELM S., DUBOIS C. et al. (1991) Purification and properties of sialoadhesin, a sialic acid-binding receptor of murine tissue macrophages. EMBO J 10, 1661.
12. 12. CROCKER P.R., FREEMAN S., GORDON S. & KELM S. (1995) Sialoadhesin binds preferentially to cells of the granulocytic lineage. J Clin Invest 95, 635.
13. 13. KLEM S., SCHAUER R., MANUGUERRA J.-C., GROSS H.-J. & CROCKER P.R. (1994) Modifications of cell surface sialic acids modulate cell adhesion mediated by sialoadhesin and CD22. Glycoconj J 11, 576.
14. 14. CROCKER P.R., WERB Z., GORDON S, & BAINTON D.F. (1990) Ultrastructural localization of a macrophage-restricted sialic acid binding hemagglutinin, SER, in macrophage hematopoietic cell clusters. Blond 76, 1131.
15. 15. BURCHELL J., DURBIN H. & TAYLOR-PAPADIMITRIOU J. (1983) Complexity of expression of antigenic determinants, recognized by monoclonal antibodies HMFG-1 and HMFG-2, in normal and malignant human mammary epithelial cells. J Immunol 131, 508.
16. 16. BURCHELL J., GENDLER S., TAYLOR-PAPADIMITRIOU J. et al. (1987) Development and characterisation of breast cancer reactive monoclonal antibodies directed to the core protein of the human milk mucin. Cancer Res 47, 5476.
17. 17. BURCHELL J., TAYLOR-PAPADIMITRIOU J., BOSHELL M., GENDLER S. & DUHIG T. (1989) A short sequence, within the amino acid tandem repeat of a cancer-associated mucin, contains immunodominant epitopes. Int J Cancer 44, 691.
18. 18. PRICE M.R., CLARKE A.J., ROBERTSON J.F., O'SULLIVAN C., BALDWIN R.W. & BLAMEY R.W. (1990) Detection of polymorphic epithelial mucins in the serum of systemic breast cancer patients using the monoclonal antibody, NCRC-11. Cancer Immunol Immunother 31, 269.
19. 19. PEMBERTON L., TAYLOR-PAPADIMITRIOU J. & GENDLER S.J. (1992) Antibodies to the cytoplasmic domain of the MUC1 mucin show conservation throughout mammals. Biochem Biophys Res Commun 185, 167.
20. 20. STEINIGER B., BARTH P., HERBST B., HARTNELL A. & CROCKER P.R. (1997) The species-specific structure of microanatomical compartments in the human spleen: strongly sialoadhesin-positive macrophages occur in the perifollicular zone, but not in the marginal zone. Immunology 92, 307.
21. 21. GIRLING A., BARTKOVA J., BURCHELL J., GENDLER S., GILLETT C. & TAYLOR-PAPADIMITRIOU J. (1989) A core protein epitope of the polymorphic epithelial mucin detected by the monoclonal antibody SM-3 is selectively exposed in a range of primary carcinomas. Int J Cancer 43, 1072.
22. 22. CUMMINGS R.D. (1993) Structural characterisation of N-glycans obtaind from metabolically-radiolabelled glycoproteins. In: Glycobiology a Practical Approach (eds M. Fukuda & A. Kobata), p. 243. IRL Press, Oxford.
23. 23. LLOYD K.O., BURCHELL J., KUDRYASHOV V., YIN B.W.T. & TAYLOR-PAPADIMITRIOU J. (1996) Comparison of O-linked carbohydrate chains in MUC-1 mucin from normal breast epithelial cell lines and breast carcinoma cell lines. Demonstration of simpler and fewer glycan chains in tumor cells. J Biol Chem 271, 33 325.
24. 24. GENDLER S.J., LANCASTER C.A., TAYLOR-PAPADIMITRIOU J. et al. (1990) Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin. J Biol Chem 265, 15286.
25. 25. CYSTER J.G., SHOTTON D.M. & WILLIAMS A.F. (1991) The dimensions of the T lymphocyte glycoprotein leukosialin and identification of linear protein epitopes that can be modified by glycosylation. EMBO J 10, 893.
26. 26. LI F., ERICKSON H.P., JAMES J.A., MOORE K.L., CUMMINGS R.D. & MCEVER R.P. (1996) Visualization of P-selectin glycoprotein ligand-1 as a highly extended molecule and mapping of protein epitopes for monoclonal antibodies. J Biol Chem 271, 6342.
27. 27. WESSELING J., VAN DER VALK. S.W. & HILKENS J. (1996) A mechanism for inhibition of E-cadherin-mediated cell cell adhesion by the membrane-associated mucin episialin/MUC1. Mol Biol Cell 7, 565.
28. 28. LIGTENBERG M.J., BOUS F., VOS H.L. & HILKENS J. (1992) Suppression of cellular aggregation by high levels of episialin. Cancer Res 52, 2318.
29. 29. CROCKER P.R. & FEIZI T. (1996) Carbohydrate recognition systems: functional triads in cell cell interactions. Curr Opin Struct Biol 6, 679.
30. 30. HULL S.R., BRIGHT A., CARRAWAY K.L., ABE M., HAYES D.F. & KUFE D.W. (1989) Oligosaccharide differences in the DF3 sialomucin antigen from normal human milk and the BT-20 human breast carcinoma cell line. Cancer Commun 1, 261.
31. 31. HANISCH F.G., STADIE T.R., DEUTZMAN F. & PETER-KATALINIC J. (1996) MUC1 glycoforms in breast cancer-cell line T47D as a model for carcinoma-associated alterations of O-glycosylation. Eur J Biochem 236, 318.
32. 32. BROCKHAUSEN I., YANG J.M., BURCHELL J., WHITEHOUSE C. & TAYLOR-PAPADIMITRIOU J. (1995) Mechanisms underlying aberrant glycosylation of MUC1 mucin in breast cancer cells Eur J Biochem 233, 607.
33. 33. VAN DE WIEL-VAN KEMENADE E., LIGTENBERG M.J., DE BOER A.J. et al. (1993) Episialin (MUC1) inhibits cytotoxic lymphocyte target cell interaction. J Immunol 151, 767.
34. 34. BOHM C.M., MULDER M.C., ZENNADI R. et al. (1997) Carbohydrate recognition on MUC1-expressing targets enhances cytotoxicity of a T cell subpopulation. Scand J Immunol 46, 27.
35. 35. JEROME K.R., BARND D.L., BENDT K.M. et al. (1991) Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells. Cancer Res 51, 2908.
36. 36. REGIMHALD L.H., PILARSKI L.M., LONGENECKER B.M., REDDISH M.A., ZIMMERMANN G. & HUGH J.C. (1996) The breast mucin MUC1 as a novel adhesion ligand for endothelial intercellular adhesion molecule 1 in breast cancer. Cancer Res 56, 4244.
37. 37. MORRIS L., CROCKER P.R., FRASER I., HILL M. & GORDON S. (1991) Expression of a divalent cation-dependent erythroblast adhesion receptor by stromal macrophages from murine bone marrow. J Cell Sci 99, 141.
38. 38. VAN DEN BERG T.K., BREVE J.J., DAMOISEAUX J.G. et al. (1992) Sialoadhesin on macrophages: its identification as a lymphocyte adhesion molecule. J Exp Med 176, 647.
39. 39. UMANSKY V., BECKHOVE P., ROCHA M., KRUGER A., CROCKER P.R. & SCHTRRMACHER V. (1996) A role for sialoadhesin-positive tissue macrophages in host resistance to lymphoma metastasis in vivo. Immunology 87, 303.
40. 40. BURCHELL J., WANG D. & TAYLOR-PAPADIMITRIOU J. (1984) Detection of the tumour-associated antigens recognized by the monoclonal antibodies HMFG-1 and 2 in serum from patients with breast cancer. Int J Cancer 34, 763.
41. 41. BOSHELL M., LALANI E.N., PEMBERTON L., BURCHELL J., GENDLER S. & TAYLOR-PAPADIMITRIOU J. (1992) The product of the human MUC1 gene when secreted by mouse cells transfected with the full-length cDNA lacks the cytoplasmic tail. Biochem Biophys Res Commun 185, 1.
42. 42. SPICER A.P., ROWSE G.J., LIDNER T.K. & GENDLER S.J. (1995) Delayed mammary tumor progression in Muc-1 null mice. J Biol Chem 270, 30 093.